Neuropsychopharmacology is an international scientific journal and an official publication of the American College of Neuropsychopharmacology (ACNP). This journal focuses upon clinical and basic science contributions that advance our understanding of the brain and behavior, especially as related to the molecular, cellular, physiological and psychological properties of agents acting within the central nervous system and the identification of the new molecular targets for the development of the next generation of drugs. While original reports are preferred, mini-reviews and perspectives are invited by the editorial office.
With a 2023 impact factor of 6.6, Neuropsychopharmacology (NPP) ranks 17 of 279 Psychiatry journals, 21 of 354 Pharmacology and Pharmacy journals, and 28 of 310 Neuroscience journals. The journal has a 2023 CiteScore of 15.0. In 2024, on average, articles received a first decision within 8 days and an accept decision within 103 days from NPP; manuscripts publish online in 15 days from the time they are received by production.
In 2024, NPP saw more than 4.5 million article downloads. That year, the journal’s bimonthly podcasts, or BrainPods, generate roughly 168 weekly listens on topics that showcase advancements in our understanding of the brain and behavior. Check us out at www.nature.com/npp!
In view of the interdisciplinary nature of the field, particular emphasis is placed on:
-
studies that advance the biological bases of normal and pathological behavior
-
the nature, etiology and pathophysiology of neuropsychiatric disorders
-
biologically relevant aspects of the epidemiology, diagnosis, and treatment of these disorders
-
the basic mechanisms by which psychopharmacological agents exert their effect
Drs. Lisa Monteggia, Ph.D. & Tony P. George, M.D., FRCPC
Co-Principal Editors
Leah Mayo, Ph.D.
NPP Social Media Editor
Instructions for Authors
Submission & Editorial Policy
Instructions for Reviewers
Criteria for Publication
(includes initial evaluation for compliance)
Process
(includes suitability for review and selection of reviewers)
Confidentiality
(includes strict guidelines)
Conflict of Interest
(includes fairness and potential biases)
Ethical Considerations
(includes breaches of publication policy)
Are you receiving Neuropsychopharmacology e-alerts?
Sign up with your e-mail address to receive monthly table of contents alerts and keep informed with Neuropsychopharmacology news and announcements. Each e-alert features the latest journal commentaries, circumspectives, original research and review articles.